May 11, 2016:
Cellanyx Demonstrates Clinical Validation of a Novel Live-Cell Phenotypic Biomarker-based Diagnostic Assay for Prostate Cancer.
Best Poster Award, 2016 American Urological Association, Prostate Cancer Markers II Moderated Poster Session
January 20, 2016:
Cellanyx Diagnostics Demonstrates a Novel Live-Cell Microfluidics Platform and Latest Data at IPCU in Colorado, 2016
Link to Poster
January 7, 2016:
Cellanyx Diagnostics Presents Latest Clinical Data in Poster Presentation at ASCO – GU Symposium, 2016
Link to Poster
December 7, 2015:
Cellanyx Diagnostics Presents Latest Clinical Data in Poster Presentation at the SUO(Society for Urologic Oncology) Winter Meeting
Link to Poster
July 23, 2015:
Recent Press Highlights Cellanyx’s Progress
Boston Business Journal
Wall Street Journal: Daily Startup Blog
Urology Times
Dow Jones Private Equity & Venture Capital News Portal
May 15, 2015:
Cellanyx Diagnostics Presents Latest Clinical Data in Poster Presentation at the Annual AUA Meeting
Link to Poster
April 22, 2015:
Cellanyx Presents Phenotypic Test Data For Prostate Cancer Risk Stratification at the AACR Annual Meeting
Link to Poster
February 20, 2015:
Cellanyx Diagnostics Announces First Clinical Data with a Novel Live Tumor Cell, Phenotypic Biomarker Test in Prostate Cancer
Link to Poster
January 26, 2015:
Cellanyx gaining traction through startup competition success
July 24, 2014:
Cellanyx CEO on establishing operations in Boston
November 12, 2013:
Cellanyx announces Series A1 Funding Round
July 12, 2013:
Cellanyx joins StartX Mentor Labs
July 1, 2013:
Cellanyx welcomes Dr. David Albala and Dr. Catherine Fink to its Senior Advisory Board.
June 4, 2013:
Cellanyx named semifinalist at Founder.org competition
June 1, 2013:
Cellanyx welcomes Dr. Kevin Knopf to its Senior Advisory Board.
May 17, 2013:
Cellanyx CEO Ashok Chander interviewed for Boston Business Journal
May 1, 2013:
Cellanyx named semifinalist at Berkeley Venture Lab competition
May 1, 2013:
Cellanyx welcomes Ms. Ann Whittaker to its Senior Advisory Board.
April 26, 2013:
Cellanyx welcomes Mr. Imran Nasrullah to its Senior Advisory Board.
April 10, 2013:
Cellanyx wins M2D2 Venture Competition
April 9, 2013:
Cellanyx presents at Merck’s Early-Stage Life Sciences Technology Conference
April 4, 2013:
Cellanyx wins Boston University’s New Venture Competition
March 15, 2013:
Cellanyx welcomes Dr. Samuel Sia to its Senior Advisory Board.
March 1, 2013:
Cellanyx welcomes Dr. Una Ryan and Dr. Edward R. Berger to its Senior Advisory Board.
February 15, 2013:
Cellanyx welcomes Mr. Peter Parker to its Senior Advisory Board.
February 1, 2013:
Cellanyx welcomes Dr. Colin Brenan, Dr. Pamela Avallone, and Dr. Pravin Chaturvedi to its Senior Advisory Board.
January 17, 2013:
MedCity features Cellanyx
January 8, 2013:
Cellanyx welcomes Mr. Amar Kendale and Dr. Satish Tadikonda to its Senior Advisory Board.